Displaying 1 to 10 of 442 records
Sort by: Page:  1234567Next >>
  • 05.16.2024 HomePageContent – May 16, 2024
  • Procedure Standards – May 16, 2024
    The procedure standards will help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment.
  • Pediatric Imaging Majd-Gilday Young Investigator Award – May 16, 2024
    The PIC Majd-Gilday YIA award was developed to recognize 2 pioneers in the pediatric imaging field who have made enormous scientific contributions to our subspecialty of pediatric nuclear medicine: Dr. Massoud Majd and Dr. David Gilday. The award will be given to young scientists for outstanding research contributions to the field of pediatric nuclear medicine.
  • Past Recipients ERF PIC Young Investigator Award Winners – May 15, 2024
  • Newly Identified PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy – May 14, 2024
    The protein galectin-1 has been identified as a new PET imaging biomarker for immune checkpoint blockade therapy, allowing physicians to predict the tumor responses before beginning treatment, according to new research published in JNM.
  • SNMMI Announces Ones to Watch 2024 Selections – May 8, 2024
    SNMMI is pleased to present our annual list of early career professionals selected as Ones to Watch in 2024!
  • New PET Agent Provides Exceptional Same-Day Imaging for Clear Cell Renal Cell Carcinoma Patients – May 7, 2024
    A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer patients according to new research published in the May issue of JNM.
  • Molecular Imaging and Breast Cancer - 5/6/24 - Tucson, AZ – May 6, 2024
    Dinner Symposium - Molecular Imaging and Breast Cancer: Selecting, Diagnosing, and Evaluating Targeted Treatments
  • JNM Supplement Highlights Nuclear Medicine Innovation in China – May 6, 2024
    A new JNM supplement spotlights the role China has played in advancing global nuclear medicine, detailing significant advances in research and development as well as the clinical translation of novel radiopharmaceuticals.
  • Radiopharmaceutical Sciences Council – Apr 25, 2024
    provide a forum for members with similar interests provide expertise in the field of interest to the membership foster education in research and application of radiopharmaceutical sciences provide outreach to other professionals and organizations nurture new membership into the Society and the Council serve as a resource to SNMMI Leadership
Displaying 1 to 10 of 442 records
Page:  1234567Next >>